Aveanna Healthcare (NASDAQ:AVAH) Shares Gap Down – Should You Sell?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report)’s share price gapped down before the market opened on Wednesday. The stock had previously closed at $12.78, but opened at $12.29. Aveanna Healthcare shares last traded at $12.4710, with a volume of 1,038,627 shares.

Analyst Ratings Changes

Several analysts have weighed in on AVAH shares. Truist Financial raised their price target on Aveanna Healthcare from $11.00 to $15.00 and gave the company a “hold” rating in a report on Monday, August 24th. Raymond James Financial boosted their price objective on Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a report on Friday, August 14th. Wall Street Zen cut shares of Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 15th. UBS Group raised their target price on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the company a “neutral” rating in a research note on Friday, August 14th. Finally, BMO Capital Markets boosted their price target on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the stock an “outperform” rating in a research note on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Aveanna Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $14.06.

View Our Latest Stock Report on Aveanna Healthcare

Aveanna Healthcare Stock Down 3.2%

The firm has a market cap of $2.70 billion, a PE ratio of 10.05, a PEG ratio of 0.78 and a beta of 1.97. The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16. The company’s 50-day simple moving average is $12.08 and its two-hundred day simple moving average is $9.05.

Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last posted its earnings results on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.05. The firm had revenue of $670.48 million for the quarter, compared to analysts’ expectations of $638.61 million. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%. On average, analysts predict that Aveanna Healthcare Holdings Inc. will post 0.77 earnings per share for the current fiscal year.

Insider Buying and Selling at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 12,496,077 shares of Aveanna Healthcare stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $143,704,885.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 14,500,002 shares of the business’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $166,750,023.00. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 48,566,081 shares of company stock valued at $558,509,932. 5.30% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Aveanna Healthcare

Hedge funds have recently bought and sold shares of the business. BlackRock Inc. purchased a new stake in Aveanna Healthcare in the second quarter worth approximately $63,504,000. Braidwell LP lifted its holdings in Aveanna Healthcare by 39.1% in the second quarter. Braidwell LP now owns 3,065,106 shares of the company’s stock valued at $26,268,000 after acquiring an additional 861,600 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Aveanna Healthcare by 49.5% in the first quarter. Dimensional Fund Advisors LP now owns 1,334,374 shares of the company’s stock valued at $8,593,000 after acquiring an additional 441,707 shares during the period. Assenagon Asset Management S.A. boosted its position in Aveanna Healthcare by 16.4% in the first quarter. Assenagon Asset Management S.A. now owns 951,594 shares of the company’s stock worth $6,128,000 after purchasing an additional 134,043 shares during the last quarter. Finally, Hillsdale Investment Management Inc. grew its stake in shares of Aveanna Healthcare by 4.3% during the 1st quarter. Hillsdale Investment Management Inc. now owns 927,030 shares of the company’s stock valued at $5,970,000 after purchasing an additional 38,600 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.

About Aveanna Healthcare

(Get Free Report)

Aveanna Healthcare Corporation is a provider of home-based healthcare services for children, adults and families in the United States. The company’s services are designed to help patients receive medical and supportive care in their homes and communities, including individuals with complex, chronic or medically fragile conditions.

Aveanna’s principal services include private-duty nursing, home health, hospice and personal care. It also provides pediatric therapy and related clinical services, including physical, occupational and speech therapy.

Featured Stories

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.